(Recasts with context, details, share price indication) ZURICH, Sept 8 (Reuters) – Swiss drugmaker Novartis on Tuesday said its experimental drug for a muscle wasting disorder failed in a late-stage
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Musk says SpaceX raised $40 billion in debt for GPUs
Oct 25 (Reuters) - Elon Musk said SpaceX had closed $40 billion in debt financing…
De Marchi and Lang make strong start at Gravel Burn
VIDEO SHOWS: HIGHLIGHTS FROM STAGE ONE OF THE NEDBANK GRAVEL BURN, A 7-DAY GRAVEL BIKE…
Final round in Bermuda scrapped; 2-man playoff set for Monday morning
The Butterfield Bermuda Championship is headed for a Monday playoff between Seamus Power and Austin…
